Search filters

List of works by Stephen V Liu

A Phase II Study of Halichondrin B Analog Eribulin Mesylate (E7389) in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with a Taxane: A California Cancer Consortium Trial ⬇️

scientific article published on March 1, 2012

A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer.

scientific article published on 12 March 2018

A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies

scientific article published in February 2018

A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors

scientific article published on 20 August 2018

Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer

scientific article published on 09 August 2018

Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial

scientific article published on 17 August 2017

Case report of perforation of an ileal neobladder after treatment of rectal cancer with bevacizumab and comment on mechanisms of intestinal perforation associated with bevacizumab ⬇️

scientific article published on March 20, 2012

Chemo-immunotherapy as first-line treatment for small-cell lung cancer

scientific article published on 18 December 2020

Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers.

scientific article

Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer

scientific article

Effect of luteinizing hormone on the steroidogenic pathway in prostate cancer.

scientific article published on 17 November 2010

Effects of luteinizing hormone receptor signaling in prostate cancer cells.

scientific article published on 12 November 2014

Emerging protein kinase inhibitors for non-small cell lung cancer

scientific article published on 20 December 2013

Expression of receptors for luteinizing hormone-releasing hormone (LH-RH) in prostate cancers following therapy with LH-RH agonists.

scientific article published on 29 July 2010

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

article by Leora Horn et al published 25 September 2018 in The New England Journal of Medicine

First-line EGFR TKI therapy in non-small-cell lung cancer: looking back before leaping forward

scientific article published on 01 December 2019

Genomic analysis and selected molecular pathways in rare cancers ⬇️

scientific article published on November 29, 2012

Genomics-based early-phase clinical trials in oncology: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies

scientific article published on 15 September 2014

Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized Potential

scientific article published on 17 June 2019

Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4.

scientific article

Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma.

scientific article

Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non-small-cell lung cancer

scientific article published on 24 July 2018

Lung cancer in 2013: Refining standard practice and admitting uncertainty

scientific article published on 21 January 2014

Lung cancer: First-line immunotherapy in lung cancer - taking the first step

scientific article published on 13 September 2016

Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma.

scientific article published on 6 June 2015

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.

scientific article published on 22 March 2017

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study

scientific article published on 16 February 2018

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

scientific article published on 25 January 2018

Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung

scientific article published on 01 July 2020

Phase I, dose-escalation study of the targeted cytotoxic LHRH analog AEZS-108 in patients with castration- and taxane-resistant prostate cancer

scientific article

Product review on the Anti-PD-L1 Antibody Atezolizumab

scientific article published in December 2017

Racial Disparities in the Molecular Landscape of Cancer

scientific article published in April 2018

Refining the treatment of NSCLC according to histological and molecular subtypes

scientific article published on 12 May 2015

Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).

scientific article published on 9 February 2017

Tarloxotinib is a hypoxia-activated pan-HER kinase inhibitor active against a broad range of HER-family oncogenes

scientific article published on 22 December 2020

The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations

scientific article published in 2022

Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series

scientific article published on 27 August 2020

Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcoma.

scientific article published on 18 April 2011

Thermoresponsive release of viable microfiltrated Circulating Tumor Cells (CTCs) for precision medicine applications.

scientific article published on October 2015

Thymomas: the need for prospective studies.

scientific article

Tracking the tail

scientific article published on 01 September 2020

alpha4 integrin is expressed in a subset of cranial neural crest cells and in epicardial progenitor cells during early mouse development.

scientific article published in January 2001

Paulina is supported by:

About Paulina

Help